Investigating therapies in ependymoma

作者: Brett J. Theeler , Mark R. Gilbert

DOI: 10.1080/21678707.2016.1191347

关键词:

摘要: … gain on 1q23 containing the candidate oncogene DUSP12 were identified in one study [60]. … proteins including vascular endothelial growth factor (VEGF), and expression of VEGF-A is …

参考文章(103)
Jacob L Jaremko, LBO Jans, Lee T Coleman, Michael R Ditchfield, None, Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors. American Journal of Neuroradiology. ,vol. 31, pp. 1613- 1616 ,(2010) , 10.3174/AJNR.A2155
Klaus Elenius, Michele Connelly, David W. Ellison, Adrian J. Frank, Cynthia Wetmore, Hannu Haapasalo, Teemu T. Junttila, Tom Curran, Richard J. Gilbertson, Roberto Hernan, Lyndsay Bentley, ERBB Receptor Signaling Promotes Ependymoma Cell Proliferation and Represents a Potential Novel Therapeutic Target for This Disease Clinical Cancer Research. ,vol. 8, pp. 3054- 3064 ,(2002)
Hazel A. Rogers, Cerys Mayne, Rebecca J. Chapman, John-Paul Kilday, Beth Coyle, Richard G. Grundy, PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival Clinical Cancer Research. ,vol. 19, pp. 6450- 6460 ,(2013) , 10.1158/1078-0432.CCR-13-0222
Q. T. Ostrom, H. Gittleman, P. Liao, C. Rouse, Y. Chen, J. Dowling, Y. Wolinsky, C. Kruchko, J. Barnholtz-Sloan, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-oncology. ,vol. 16, ,(2012) , 10.1093/NEUONC/NOU223
Mark P McLaughlin M.D., Robert B Marcus Jr., M.D., John M Buatti M.D., W.Mark McCollough M.D., J.Parker Mickle M.D., Amos Kedar M.D., Bernard L Maria M.D., Rodney R Million M.D., Ependymoma: Results, Prognostic Factors and Treatment Recommendations International Journal of Radiation Oncology Biology Physics. ,vol. 40, pp. 845- 850 ,(1998) , 10.1016/S0360-3016(97)00893-6
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues, None, The 2007 WHO Classification of Tumours of the Central Nervous System Acta Neuropathologica. ,vol. 114, pp. 97- 109 ,(2007) , 10.1007/S00401-007-0243-4
DC Weber, R Miller, S Villa, SP Kadish, Y Anacak, H Abusaris, G Ozygit, B Baumert, R Zaucha, A Pica, The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. International Journal of Radiation Oncology Biology Physics. ,vol. 74, pp. 1114- 1120 ,(2008) , 10.1016/J.IJROBP.2008.09.034
Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang, Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Journal of Clinical Oncology. ,vol. 28, pp. 1963- 1972 ,(2010) , 10.1200/JCO.2009.26.3541
Richard G Grundy, Sophie A Wilne, Claire L Weston, Kath Robinson, Linda S Lashford, James Ironside, Tim Cox, W Kling Chong, Richard HA Campbell, Cliff C Bailey, Rao Gattamaneni, Sue Picton, Nicky Thorpe, Conor Mallucci, Martin W English, Jonathan AG Punt, David A Walker, David W Ellison, David Machin, Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. web science. ,vol. 8, pp. 696- 705 ,(2007) , 10.1016/S1470-2045(07)70208-5
Thomas E Merchant, Chenghong Li, Xiaoping Xiong, Larry E Kun, Frederic A Boop, Robert A Sanford, Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study Lancet Oncology. ,vol. 10, pp. 258- 266 ,(2009) , 10.1016/S1470-2045(08)70342-5